These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1292713)

  • 21. SDS-PAGE for identification of species belonging to the Mycobacterium fortuitum complex.
    Esteban J; Molleja A; Cabria F; Soledad Jiménez M
    Clin Microbiol Infect; 2003 Apr; 9(4):327-31. PubMed ID: 12667246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of beta-lactamase production to the resistance of mycobacteria to beta-lactam antibiotics.
    Quinting B; Reyrat JM; Monnaie D; Amicosante G; Pelicic V; Gicquel B; Frère JM; Galleni M
    FEBS Lett; 1997 Apr; 406(3):275-8. PubMed ID: 9136901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A study of beta-lactamase activity of mycobacteria and clinical trial of penicillin/beta-lactamase inhibitor combinations in the treatment of drug-resistant Mycobacterium tuberculosis].
    Nakagawa Y; Shimazu K; Ebihara M; Aman K
    Kekkaku; 1999 May; 74(5):447-52. PubMed ID: 10386034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent changes in taxonomy and disease manifestations of the rapidly growing mycobacteria.
    Wallace RJ
    Eur J Clin Microbiol Infect Dis; 1994 Nov; 13(11):953-60. PubMed ID: 7698122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and some properties of beta-lactamase from Mycobacterium fortuitum.
    Fattorini L; Oliva B; Orefici G
    Drugs Exp Clin Res; 1986; 12(12):973-7. PubMed ID: 3494588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycobacterium chelonei.
    Grange JM
    Tubercle; 1981 Dec; 62(4):273-6. PubMed ID: 7336476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-performance liquid chromatography patterns of mycolic acids as criteria for identification of Mycobacterium chelonae, Mycobacterium fortuitum, and Mycobacterium smegmatis.
    Butler WR; Kilburn JO
    J Clin Microbiol; 1990 Sep; 28(9):2094-8. PubMed ID: 2229390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Identification of clinically important strains of Mycobacterium fortuitum complex].
    Sosnovskaia AV
    Probl Tuberk; 1989; (10):40-3. PubMed ID: 2687843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of rapidly growing Mycobacteria isolates in a general hospital: reports from the hospital microbiology laboratory].
    Tazawa S; Marumo K; Nakamura Y; Narushima M; Higuchi D
    Kekkaku; 2001 May; 76(5):419-26. PubMed ID: 11449697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of INNO-LiPA mycobacteria v2 assay for identification of rapidly growing mycobacteria.
    García-Agudo L; Jesús I; Rodríguez-Iglesias M; García-Martos P
    Braz J Microbiol; 2011 Jul; 42(3):1220-6. PubMed ID: 24031745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Susceptibility to antimicrobial agents of rapidly growing mycobacteria].
    Ruiz-Aragón J; García-Agudo L; Flores S; Rodríguez MJ; Marín P; García-Martos P
    Rev Esp Quimioter; 2007 Dec; 20(4):429-32. PubMed ID: 18563216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the distribution of non-tuberculous mycobacteria strains isolated in National Tuberculosis Reference Laboratory in 2009-2010, Turkey].
    Albayrak N; Simşek H; Sezen F; Arslantürk A; Tarhan G; Ceyhan I
    Mikrobiyol Bul; 2012 Oct; 46(4):560-7. PubMed ID: 23188570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Assessment of the invasiveness of rapidly-growing nonpigmented mycobacteria with the fibroblast microcolony assay].
    Esteban J; Gadea I; Zamora N; Ortiz A; Fernández-Roblas R
    Enferm Infecc Microbiol Clin; 2006 Nov; 24(9):551-5. PubMed ID: 17125673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates.
    Hoel T; Casals JB; Eng J
    APMIS; 1993 Jan; 101(1):27-32. PubMed ID: 8457323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deoxyribonucleic acid relatedness among species of rapidly growing mycobacteria.
    Baess I
    Acta Pathol Microbiol Immunol Scand B; 1982 Oct; 90(5):371-5. PubMed ID: 7148460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery.
    Wallace RJ; Musser JM; Hull SI; Silcox VA; Steele LC; Forrester GD; Labidi A; Selander RK
    J Infect Dis; 1989 Apr; 159(4):708-16. PubMed ID: 2926161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structures of the glycolipid antigens of members of the third biovariant complex of Mycobacterium fortuitum.
    Lanëelle MA; Silve G; López Marín LM; Daffé M
    Eur J Biochem; 1996 May; 238(1):270-9. PubMed ID: 8665946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of clinically significant Mycobacterium fortuitum complex isolates.
    Silcox VA; Good RC; Floyd MM
    J Clin Microbiol; 1981 Dec; 14(6):686-91. PubMed ID: 7037841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta-Lactamase activity in mycobacteria including Mycobacterium avium and suppression of their growth by a beta-lactamase-stable antibiotic.
    Prabhakaran K; Harris EB; Randhawa B; Hastings RC
    Microbios; 1995; 81(328):177-85. PubMed ID: 7752957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.